A vaccination campaign to prevent teenagers from taking up smoking would be too expensive to recommend, according to Australian researchers who looked at the costs and benefits of anti-nicotine shots in development.

Taking into account the effectiveness demonstrated so far by experimental vaccines designed to help smokers quit, the team concluded the drugs would need to be cheaper, require fewer doses and get better results for widespread preventive vaccination of teens to be worthwhile.